BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 14691453)

  • 21. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
    Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
    Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers.
    Youssef EM; Chen XQ; Higuchi E; Kondo Y; Garcia-Manero G; Lotan R; Issa JP
    Cancer Res; 2004 Apr; 64(7):2411-7. PubMed ID: 15059893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of epigenetically masked tumor suppressor genes in endometrial cancer.
    Takai N; Kawamata N; Walsh CS; Gery S; Desmond JC; Whittaker S; Said JW; Popoviciu LM; Jones PA; Miyakawa I; Koeffler HP
    Mol Cancer Res; 2005 May; 3(5):261-9. PubMed ID: 15886297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer.
    Ellinger J; Bastian PJ; Jurgan T; Biermann K; Kahl P; Heukamp LC; Wernert N; Müller SC; von Ruecker A
    Urology; 2008 Jan; 71(1):161-7. PubMed ID: 18242387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
    Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
    Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple tumor suppressor genes are increasingly methylated with age in non-neoplastic gastric epithelia.
    So K; Tamura G; Honda T; Homma N; Waki T; Togawa N; Nishizuka S; Motoyama T
    Cancer Sci; 2006 Nov; 97(11):1155-8. PubMed ID: 16952303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional epigenomics identifies genes frequently silenced in prostate cancer.
    Lodygin D; Epanchintsev A; Menssen A; Diebold J; Hermeking H
    Cancer Res; 2005 May; 65(10):4218-27. PubMed ID: 15899813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between RAR-beta gene expression defect and its methylation].
    Gao YP; Li M; Zhang YY; Wang H; He XH; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):472-6. PubMed ID: 17961338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation of the CD44 metastasis suppressor gene in human prostate cancer.
    Lou W; Krill D; Dhir R; Becich MJ; Dong JT; Frierson HF; Isaacs WB; Isaacs JT; Gao AC
    Cancer Res; 1999 May; 59(10):2329-31. PubMed ID: 10344738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypermethylation-associated inactivation of retinoic acid receptor beta in human esophageal squamous cell carcinoma.
    Wang Y; Fang MZ; Liao J; Yang GY; Nie Y; Song Y; So C; Xu X; Wang LD; Yang CS
    Clin Cancer Res; 2003 Nov; 9(14):5257-63. PubMed ID: 14614007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Methylation of promoter region of RAR-beta2 gene in renal cell, breast, and ovarian carcinomas].
    Khodyrev DS; Loginov VI; Pronina IV; Kazubskaia TP; Gar'kavtseva RF; Braga EA
    Genetika; 2008 Aug; 44(8):1126-32. PubMed ID: 18825962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between methylation profile of promoter cpg islands of seven metastasis-associated genes and their expression states in six cell lines of liver origin.
    Li JL; Fei Q; Yu J; Zhang HY; Wang P; Zhu JD
    Ai Zheng; 2004 Sep; 23(9):985-91. PubMed ID: 15363188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer.
    Shiina H; Breault JE; Basset WW; Enokida H; Urakami S; Li LC; Okino ST; Deguchi M; Kaneuchi M; Terashima M; Yoneda T; Shigeno K; Carroll PR; Igawa M; Dahiya R
    Cancer Res; 2005 Mar; 65(6):2130-8. PubMed ID: 15781623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
    Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
    Rosenbaum E; Hoque MO; Cohen Y; Zahurak M; Eisenberger MA; Epstein JI; Partin AW; Sidransky D
    Clin Cancer Res; 2005 Dec; 11(23):8321-5. PubMed ID: 16322291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
    Soejima H; Nakagawachi T; Zhao W; Higashimoto K; Urano T; Matsukura S; Kitajima Y; Takeuchi M; Nakayama M; Oshimura M; Miyazaki K; Joh K; Mukai T
    Oncogene; 2004 May; 23(25):4380-8. PubMed ID: 15007390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells.
    Grunt TW; Puckmair K; Tomek K; Kainz B; Gaiger A
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1253-9. PubMed ID: 15766561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypermethylation in promoter region of retinoic acid receptor-beta gene and immunohistochemical findings on retinoic acid receptors in carcinogenesis of endometrium.
    Li R; Saito T; Tanaka R; Satohisa S; Adachi K; Horie M; Akashi Y; Kudo R
    Cancer Lett; 2005 Feb; 219(1):33-40. PubMed ID: 15694662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification.
    Misawa A; Inoue J; Sugino Y; Hosoi H; Sugimoto T; Hosoda F; Ohki M; Imoto I; Inazawa J
    Cancer Res; 2005 Nov; 65(22):10233-42. PubMed ID: 16288011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.